MedTrace Logo

A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

NCT07547995 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2026-04-23

No results posted yet for this study

Summary

This study is designed to evaluate the efficacy and safety of GenSci048 compared with placebo in subjects with active non-infectious uveitis.

Conditions

  • Uveitis

Interventions

DRUG

GenSci048 High-dose

High-dose Administered SC.

DRUG

GenSci048 Low-dose

Low-dose Administered SC.

DRUG

Placebo

Administered SC.

Sponsors & Collaborators

  • Changchun GeneScience Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-18
Primary Completion
2027-12-14
Completion
2028-01-13

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07547995 on ClinicalTrials.gov